• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2000-2009  

Melatonin as an adjuvant to therapeutic prostate cancer vaccines

Print Email
Published on Friday, 27 March 2015

Letter to the Editor

 



Download the complete article

 

About this Letter.

 

See also About Melatonin.

 


 

Comment on

Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment

Search

Follow us...

Latest

  • Melatonin: an endogenous miraculous indolamine, fights against cancer progression
  • Melatonin and breast cancer: Evidences from preclinical and human studies
  • Melatonin induces autophagy in neuroblastoma by alleviating Pak2‑mediated endoplasmic reticulum stress
  • In vivo dynamic monitoring of self-assembled melatonin nanodrug combined with photothermal effects to alleviate hypoxia to attenuate tumor aggressiveness
  • Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
  • Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
  • Plasma melatonin and the hormone-dependency of human breast cancer
  • Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
  • Melatonin: A Molecule for Reducing Breast Cancer Risk
  • Melatonin: an inhibitor of breast cancer
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • The Intricate Relationship between Melatonin and Breast Cancer: A Short Review
  • Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis
  • Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30,000 cancer deaths per year
  • Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
  • Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process
  • The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
  • Melatonin's protective effect on the salivary gland against ionized radiation damage in rats

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer